Inventor · disambiguated record
Claudio Pietra
Also filed as: PIETRA CLAUDIO
22 granted patents·7 pending applications·53 citations·filing 1997–2025
93Inventor score
Top patents by PatentIndex Score
29 records- 0194US8426450B1Substituted 4-phenyl pyridines having anti-emetic effectFADINI LUCA·Filed 2012·Granted Apr 23, 2013·22 cites·3 claims
- 0289US10208073B2Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulatorHELSINN HEALTHCARE SA·Filed 2018·Granted Feb 19, 2019·2 cites·13 claims
- 0385US9403772B24-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulatorHELSINN HEALTHCARE SA·Filed 2012·Granted Aug 2, 2016·4 cites·14 claims
- 0483US9546157B2Asymmetric piperidinyl-substituted ureas as medicinesHELSINN HEALTHCARE SA·Filed 2015·Granted Jan 17, 2017·4 cites·38 claims
- 0581US12440485B2Centrally-active ghrelin agonist and medical uses thereofHELSINN HEALTHCARE SA·Filed 2024·Granted Oct 14, 2025·0 cites·28 claims
- 0680US8658797B2Asymmetric ureas and medical uses thereofGARCIA RUBIO SILVINA·Filed 2012·Granted Feb 25, 2014·7 cites·19 claims
- 0779US12071421B2Process for the synthesis of substituted chloromethyl dialkylphosphatesHELSINN HEALTHCARE SA·Filed 2022·Granted Aug 27, 2024·0 cites·3 claims
- 0879US10577384B2Substituted asymmetric ureas as modulators of ghrelin receptor activityHELSINN HEALTHCARE SA·Filed 2018·Granted Mar 3, 2020·2 cites·15 claims
- 0978US12005056B2Centrally-active ghrelin agonist and medical uses thereofHELSINN HEALTHCARE SA·Filed 2019·Granted Jun 11, 2024·2 cites·22 claims
- 1078US9926337B2Substituted asymmetric ureas as modulators of ghrelin receptor activityHELSINN HEALTHCARE SA·Filed 2016·Granted Mar 27, 2018·2 cites·19 claims
- 1177US2025367181A1Centrally-Active Ghrelin Agonist and Medical Uses ThereofHELSINN HEALTHCARE SA·Filed 2025·Application pending·0 cites
- 1276US10407390B2Asymmetric ureas and medical uses thereofHELSINN HEALTHCARE SA·Filed 2017·Granted Sep 10, 2019·1 cites·3 claims
- 1375US11312698B2Fosnetupitant chloride hydrochloride having improved stabilityHELSINN HEALTHCARE SA·Filed 2020·Granted Apr 26, 2022·0 cites·12 claims
- 1471US10717721B2Substituted piperaziniums for the treatment of emesisHELSINN HEALTHCARE SA·Filed 2018·Granted Jul 21, 2020·0 cites·2 claims
- 1570US11884646B2Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2-trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl)urea, methods of preparation, and uses thereofHELSINN HEALTHCARE SA·Filed 2022·Granted Jan 30, 2024·0 cites·27 claims
- 1667US9908907B2Substituted piperaziniums for the treatment of emesisHELSINN HEALTHCARE SA·Filed 2016·Granted Mar 6, 2018·0 cites·6 claims
- 1764US8895586B2Methods of treating emesisFADINI LUCA·Filed 2013·Granted Nov 25, 2014·0 cites·21 claims
- 1863US2020262850A1Substituted asymmetric ureas as modulators of ghrelin receptor activityHELSINN HEALTHCARE SA·Filed 2020·Application pending·0 cites
- 1960US9751836B2Asymmetric ureas and medical uses thereofHELSINN HEALTHCARE SA·Filed 2014·Granted Sep 5, 2017·0 cites·49 claims
- 2059US2025205216A2Piperidine Urea Derivatives for Use as Inotropic AgentsLUND LARS·Filed 2022·Application pending·0 cites
- 2156US11299472B2Fumarate salt of (R)-3-(1-(2,3-dichloro-4-(pyrazin-2-yl)phenyl)-2,2,2- trifluoroethyl)-1-methyl-1-(1-methylpiperidin-4-yl) urea, methods of preparation, and uses thereofHELSINN HEALTHCARE SA·Filed 2018·Granted Apr 12, 2022·0 cites·22 claims
- 2253US2018177849A1Therapeutic Uses of ElsiglutideHELSINN HEALTHCARE SA·Filed 2017·Application pending·0 cites
- 2349US9358228B2Therapeutic combinations of netupitant and palonosetronHELSINN HEALTHCARE SA·Filed 2012·Granted Jun 7, 2016·0 cites·34 claims
- 2447US6114391Aα-amino acid amides, preparation thereof and the therapeutical use thereofCHIESI FARMA SPA·Filed 1997·Granted Sep 5, 2000·7 cites·14 claims
- 2541US2005222266A12-indanylamino derivatives for the therapy of chronic painCHIESI FARMA SPA·Filed 2002·Application pending·0 cites
- 2641US2017087216A1Therapeutic Uses of ElsiglutideHELSINN HEALTHCARE SA·Filed 2016·Application pending·0 cites
- 2739US10501479B2Benzenesulfonyl-asymmetric ureas and medical uses thereofHELSINN HEALTHCARE SA·Filed 2017·Granted Dec 10, 2019·0 cites·51 claims
- 2834US2010261734A1Methods of Treating Bladder Dysfunction Using NetupitantHELSINN HEALTHCARE SA·Filed 2010·Application pending·0 cites
- 2927US6297237B1Process for the preparation of aminocarbonyl derivatives of geneseroline having selective brain anticholinesterase activityCHIESI FARMA SPA·Filed 1998·Granted Oct 2, 2001·0 cites·35 claims
Join the waitlist — get patent alerts
Get an alert when Claudio Pietra files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →